The
committed a fresh GBP18 million (USD27 million) to help develop effective treatments for tropical diseases. The funding will focus on combating "sleeping sickness," which imperils some 60 million people in impoverished African communities.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Ma. Rizza Leonzon
As a former staff writer, Rizza focused mainly on business coverage, including key donors such as the Asian Development Bank and AusAID.
